Endoscopy 2011; 43(10): 897-912
DOI: 10.1055/s-0030-1256754
Guideline
© Georg Thieme Verlag KG Stuttgart · New York

Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

J.-M. Dumonceau
1   Service of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland
,
M. Polkowski
2   Department of Gastroenterology and Hepatology, Medical Centre for Postgraduate Education and Department of Gastroenterology, The M. Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
,
A. Larghi
3   Digestive Endoscopy Unit, Catholic University, Rome, Italy
,
P. Vilmann
4   Department of Surgical Gastroenterology, Herlev Hospital and Gentofte Hospital, Copenhagen University, Denmark
,
M. Giovannini
5   Endoscopic Unit, Paoli-Calmettes Institut, Marseilles, France
,
J.-L. Frossard
1   Service of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland
,
D. Heresbach
6   Endoscopic Unit, Cannes Hospital, Cannes, France
,
B. Pujol
7   Department of Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France
,
G. Fernández-Esparrach
8   Endoscopy Unit, Department of Gastroenterology, ICMDM, IDIBAPS, CIBERehd, Hospital Clínic, Barcelona, Spain
,
E. Vazquez-Sequeiros
9   Division of Gastroenterology, Hospital Ramon, University of Alcala, Cajal, Madrid, Spain
,
A. Ginès
8   Endoscopy Unit, Department of Gastroenterology, ICMDM, IDIBAPS, CIBERehd, Hospital Clínic, Barcelona, Spain
› Author Affiliations
Further Information

Publication History

31 March 2011

9 June 2011

Publication Date:
12 August 2011 (online)

Zoom Image

This article is part of a combined publication that expresses the current view of the European Society of Gastrointestinal Endoscopy (ESGE) about endoscopic ultrasound (EUS)-guided sampling in gastroenterology, including EUS-guided fine needle aspiration (EUS-FNA) and EUS-guided trucut biopsy (EUS-TCB), of submucosal tumors, diffuse esophageal/gastric wall thickening, pancreatic solid masses and cystic-appearing lesions, mediastinal lesions unrelated to lung or esophageal cancer, cancer of the esophagus, stomach, and rectum, lymph nodes of unknown origin, adrenal gland masses, and focal liver lesions. False-positive cytopathological results and needle tract seeding are also discussed. The present Clinical Guideline describes the results of EUS-guided sampling in the different clinical settings, considers the role of this technique in patient management, and makes recommendations on circumstances that warrant its use. A two-page executive summary of evidence statements and recommendations is provided. A separate Technical Guideline describes the general technique of EUS-guided sampling, particular techniques to maximize the diagnostic yield depending on the nature of the target lesion, and sample processing. The target readership for the Clinical Guideline mostly includes gastroenterologists, oncologists, internists, and surgeons while the Technical Guideline should be most useful to endoscopists who perform EUS-guided sampling.

Appendix e1 – e2 are available online: